Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimers Disease

The number of people living with dementia is expected to rise from 55 million in 2019 to 139 million in 2050, according to a report by WHO. Conventional drugs, while providing symptomatic relief, have often fallen short of halting the relentless progression of this neurodegenerative disorder. This new two-volume set represents a collective effort to delve into the potential of natures pharmacopeia in our battle against Alzheimers disease. Volume 2: Strategies to Unlock the Brains Fortress offers a comprehensive exploration into the cutting-edge strategies for the pursuit of effective Alzheimers management. It first offers a holistic exploration of nutraceuticals and their pivotal role in managing Alzheimers disease, serving as a guide to the diverse array of neuro-nutraceuticals and providing insights into their mechanisms, efficacy, and potential integration into holistic Alzheimers management strategies. The book looks at natural antioxidant therapeutics, natural steroidal phytopharmaceuticals and Terpenes (aromatic compounds found in many plants), anti-apoptotic natural products, polysaccharides, neuro-protective role of vitamin D, and non-flavonoidal agents for the effective treatment of Alzheimers. Recent developments and advancements in the delivery of nutraceuticals are explored as well, looking at nanotechnology and advanced drug delivery systems for therapeutic interventions. Volume 1: Targeting Key Pathological Pathways covers the pathophysiology and diagnosis of Alzheimers disease, its connection to gut microbiome, drug-induced Alzheimers disease, and more, also discussing the vast potential of nutraceuticals in managing Alzheimers disease. It explores a plethora of medicinal plants and their secondary metabolites that show promise in treating this devastating condition. Together, these volumes not only reflect the current state of knowledge but also pave the way for future exploration in the field.